Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

1 source entries across 1 studies. This list may not include all unresolved or historical entries.

  • BloodsamplingRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(20%)
Results Posted
50%(1 trials)
Terminated
1(20%)

Phase Distribution

Not Applicable
2
40%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
Terminated1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
66.7%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

terminated120%
recruiting120%
unknown120%
completed240%

Recent Activity

1 active trials
Showing 5 of 5
recruitingnot_applicable

Predicting Reactions and Effects of Drugs Immunotherapy and Complications Through Oncosafety (PREDICTO Clinical Study)

NCT07192315
unknown

Genome-wide Epistasis for Cardiovascular Severity in Marfan Study

NCT06257004
terminatednot_applicable

Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational Age

NCT01491854
completed

Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity

NCT01621425
completed

Copeptin for Risk Stratification in Acute Stroke Patients: the CoRisk Study

NCT00878813

Clinical Trials (5)

Showing 5 of 5 trials
NCT07192315Not Applicable

Predicting Reactions and Effects of Drugs Immunotherapy and Complications Through Oncosafety (PREDICTO Clinical Study)

Recruiting
NCT06257004

Genome-wide Epistasis for Cardiovascular Severity in Marfan Study

Unknown
NCT01491854Not Applicable

Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational Age

Terminated
NCT01621425

Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity

Completed
NCT00878813

Copeptin for Risk Stratification in Acute Stroke Patients: the CoRisk Study

Completed

All 5 trials loaded

Drug Details

Intervention Type
Varies by study
Total Trials
5